These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 16280740)

  • 41. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
    J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased expression of sialyl-Lewis A correlates with poor survival in upper urinary tract urothelial cancer patients.
    Saito K; Fujii Y; Kawakami S; Hayashi T; Arisawa C; Koga F; Kageyama Y; Kihara K
    Anticancer Res; 2003; 23(4):3441-6. PubMed ID: 12926087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival of patients with transitional cell carcinoma of the ureter and renal pelvis in Balkan endemic nephropathy and non-endemic areas of Serbia.
    Dragicevic D; Djokic M; Pekmezovic T; Micic S; Hadzi-Djokic J; Vuksanovic A; Simic T
    BJU Int; 2007 Jun; 99(6):1357-62. PubMed ID: 17346272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy.
    Harada K; Sakai I; Hara I; Eto H; Miyake H
    Int J Urol; 2005 Mar; 12(3):250-5. PubMed ID: 15828951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
    Bolenz C; Herrmann E; Bastian PJ; Michel MS; Wülfing C; Tiemann A; Buchner A; Stief CG; Fritsche HM; Burger M; Wieland WF; Höfner T; Haferkamp A; Hohenfellner M; Müller SC; Ströbel P; Trojan L
    BJU Int; 2010 Aug; 106(4):493-9. PubMed ID: 20067452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma.
    Funai K; Sugimura H; Morita T; Shundo Y; Shimizu K; Shiiya N
    Ann Surg Oncol; 2011 Oct; 18(10):2968-72. PubMed ID: 21512862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: its impact on prognosis.
    Liang P; Nakada I; Hong JW; Tabuchi T; Motohashi G; Takemura A; Nakachi T; Kasuga T; Tabuchi T
    Ann Surg Oncol; 2007 Feb; 14(2):470-7. PubMed ID: 17103258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival.
    Brausi MA; Gavioli M; De Luca G; Verrini G; Peracchia G; Simonini G; Viola M
    Eur Urol; 2007 Nov; 52(5):1414-8. PubMed ID: 17507148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Ohtsuka Y; Fujii Y; Masuda H; Kumagai J; Kobayashi T; Kageyama Y; Kihara K
    BJU Int; 2007 Aug; 100(2):269-73. PubMed ID: 17488302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
    Miyata Y; Kanda S; Nomata K; Hayashida Y; Kanetake H
    Urology; 2004 Mar; 63(3):602-8. PubMed ID: 15028476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
    Shariat SF; Svatek RS; Tilki D; Skinner E; Karakiewicz PI; Capitanio U; Bastian PJ; Volkmer BG; Kassouf W; Novara G; Fritsche HM; Izawa JI; Ficarra V; Lerner SP; Sagalowsky AI; Schoenberg MP; Kamat AM; Dinney CP; Lotan Y; Marberger MJ; Fradet Y
    BJU Int; 2010 May; 105(10):1402-12. PubMed ID: 20132195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
    Brown GA; Busby JE; Wood CG; Pisters LL; Dinney CP; Swanson DA; Grossman HB; Pettaway CA; Munsell MF; Kamat AM; Matin SF
    BJU Int; 2006 Dec; 98(6):1176-80. PubMed ID: 17125474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
    Hurel S; Rouprêt M; Ouzzane A; Rozet F; Xylinas E; Zerbib M; Berod AA; Ruffion A; Adam E; Cussenot O; Houlgatte A; Phé V; Nouhaud FX; Bensadoun H; Delage F; Guillotreau J; Guy L; Karsenty G; De La Taille A; Colin P;
    BJU Int; 2013 Jun; 111(8):1199-207. PubMed ID: 23650914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.
    Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
    Urology; 2005 Feb; 65(2):279-83. PubMed ID: 15708038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Large series of 114 cases with long-term follow-up of upper urinary tract urothelial tumors].
    Izquierdo L; Truán D; Alvarez-Vijande R; Alcaraz A
    Actas Urol Esp; 2010 Mar; 34(3):232-7. PubMed ID: 20416239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.
    Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
    J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors in invasive squamous cell carcinoma of the penis: analysis of 196 patients treated at the Brazilian National Cancer Institute.
    Ornellas AA; Nóbrega BL; Wei Kin Chin E; Wisnescky A; da Silva PC; de Santos Schwindt AB
    J Urol; 2008 Oct; 180(4):1354-9. PubMed ID: 18707720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.